TY - JOUR
T1 - Simple surface sulfonation retards plasticiser migration and impacts upon blood/material contact activation processes
AU - Gourlay, T.
AU - Shedden, L.
AU - Horne, D.C.
AU - Stefanou, D.M.
PY - 2010/1
Y1 - 2010/1
N2 - Background. The use of Di-2-ethylhexyl phthalate (DEHP) plasticised polyvinyl chloride (DEHPPPVC) in medical devices
persists despite evidence suggesting that DEHP migration can be harmful. Researchers have shown that a simple surface
sulfonation process can retard the migration of DEHP, which may reduce the associated inflammatory response. The
present study is designed to investigate the effects of surface sulfonation on DEHP migration and blood contact activation using in vitro and rodent models.
Methods. The study was carried out in two phases: phase 1, in which the migration rate of DEHP from DEHPPPVC
and sulfonated DEHP plasticised PVC (SDEHPPPVC) was measured; phase 2 of the study, in which the materials were
incorporated into a rat recirculation biomaterial test model and blood samples taken to assess CD11b expression on
neutrophils, IL-6 and Factor XIIa.
Results. The initial DEHP concentration washed from the surface after storage was 37.19 ± 1.17 mg/l in the PPVC
group and 5.89 ± 0.81 mg/l in the SPPVC group (p<0.0001). The post-wash migration rate was 3.07 ± 0.32 mg/l/hour in
the PPVC group compared to 0.46 ± 0.038 mg/l/hour in the SPPVC group (p<0.0001). In phase 2 of the study, CD11b
expression increased by 228.9% ± 37% over the test period in the PPVC group compared to 118.3% ± 46% in the SPPVC
group (p<0.01). IL-6 levels rose from 3.1 ± 1.4 pg/ml to 263 ± 26 pg/ml in the PPVC group and 2.2 ± 1.6 pg/ml to 161 ± 29 pg/ml in the SPPVC group (p<0.01). Factor XIIa levels rose from 0.22 ± 0.13 g/ml to 3.7 ± 0.32 μg/ml and 0.28 ± 0.09 to 2.71 ± 0.21 μg/ml in the PPVC and SPPVC groups, respectively (p<0.05 at 90 minutes).
Conclusions. The simple sulfonation process significantly retards the migration of DEHP and is associated with the
moderation of contact activation processes.
AB - Background. The use of Di-2-ethylhexyl phthalate (DEHP) plasticised polyvinyl chloride (DEHPPPVC) in medical devices
persists despite evidence suggesting that DEHP migration can be harmful. Researchers have shown that a simple surface
sulfonation process can retard the migration of DEHP, which may reduce the associated inflammatory response. The
present study is designed to investigate the effects of surface sulfonation on DEHP migration and blood contact activation using in vitro and rodent models.
Methods. The study was carried out in two phases: phase 1, in which the migration rate of DEHP from DEHPPPVC
and sulfonated DEHP plasticised PVC (SDEHPPPVC) was measured; phase 2 of the study, in which the materials were
incorporated into a rat recirculation biomaterial test model and blood samples taken to assess CD11b expression on
neutrophils, IL-6 and Factor XIIa.
Results. The initial DEHP concentration washed from the surface after storage was 37.19 ± 1.17 mg/l in the PPVC
group and 5.89 ± 0.81 mg/l in the SPPVC group (p<0.0001). The post-wash migration rate was 3.07 ± 0.32 mg/l/hour in
the PPVC group compared to 0.46 ± 0.038 mg/l/hour in the SPPVC group (p<0.0001). In phase 2 of the study, CD11b
expression increased by 228.9% ± 37% over the test period in the PPVC group compared to 118.3% ± 46% in the SPPVC
group (p<0.01). IL-6 levels rose from 3.1 ± 1.4 pg/ml to 263 ± 26 pg/ml in the PPVC group and 2.2 ± 1.6 pg/ml to 161 ± 29 pg/ml in the SPPVC group (p<0.01). Factor XIIa levels rose from 0.22 ± 0.13 g/ml to 3.7 ± 0.32 μg/ml and 0.28 ± 0.09 to 2.71 ± 0.21 μg/ml in the PPVC and SPPVC groups, respectively (p<0.05 at 90 minutes).
Conclusions. The simple sulfonation process significantly retards the migration of DEHP and is associated with the
moderation of contact activation processes.
KW - surface sulfonation process
KW - blood contact activation
KW - Di-2-ethylhexyl phthalate
KW - contact activation
UR - http://www.scopus.com/inward/record.url?scp=77949344257&partnerID=8YFLogxK
U2 - 10.1177/0267659110361997
DO - 10.1177/0267659110361997
M3 - Article
SN - 0267-6591
VL - 25
SP - 31
EP - 39
JO - Perfusion
JF - Perfusion
IS - 1
ER -